VIDEO: A patient’s race/ethnicity affects eligibility for acute myeloid leukemia trials
In this video, Andrew Hantel, MD, discusses the results of a study he helped present at ASCO Annual Meeting on racial disparities in acute myeloid leukemia trials.
Hantel, a medical oncologist at Dana-Farber Cancer Institute, highlighted the study, which examined hundreds of acute myeloid leukemia clinical trials and found that white patients were significantly more likely to meet eligibility criteria than nonwhite patients.
“We're going to be using some of these to really understand for future trials, how can we change some of the criteria when they're being put in place in the first place such that we can make the trials more inclusive and make it more like the patients who have the disease in the end,” Hantel said.
Collapse
Read more about